Robbins Farley’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-371
Closed -$22.9K 149
2025
Q4
$22.9K Sell
371
-28
-7% -$1.71K 0.01% 96
2025
Q3
$24.9K Sell
399
-26,968
-99% -$1.88M 0.01% 100
2025
Q2
$2.19M Sell
27,367
-335
-1% -$28K 1.02% 40
2025
Q1
$2.38M Sell
27,702
-134
-0.5% -$11K 1.26% 37
2024
Q4
$2.17M Sell
27,836
-5,418
-16% -$421K 1.03% 41
2024
Q3
$2.4M Buy
33,254
+1,774
+6% +$126K 1.21% 40
2024
Q2
$2.17M Buy
31,480
+2,240
+8% +$152K 1.15% 38
2024
Q1
$2.12M Buy
29,240
+806
+3% +$53.9K 1.12% 39
2023
Q4
$1.74M Sell
28,434
-367
-1% -$21.8K 1.04% 40
2023
Q3
$1.65M Buy
28,801
+3,719
+15% +$225K 1.11% 39
2023
Q2
$1.49M Sell
25,082
-388
-2% -$23.2K 1.03% 39
2023
Q1
$1.6M Sell
25,470
-4,829
-16% -$302K 1.07% 41
2022
Q4
$1.9M Sell
30,299
-139
-0.5% -$7.97K 1.47% 33
2022
Q3
$1.52M Buy
+30,438
New +$1.69M 1.25% 41
2022
Q2
Sell
-30,649
Closed -$1.62M 159
2022
Q1
$1.62M Sell
30,649
-1,353
-4% -$78.1K 1.22% 39
2021
Q4
$1.94M Sell
32,002
-430
-1% -$25.5K 1.43% 30
2021
Q3
$1.82M Buy
+32,432
New +$1.78M 1.34% 36
2021
Q2
Sell
-33,094
Closed -$1.55M 155
2021
Q1
$1.55M Sell
33,094
-6,259
-16% -$263K 1.36% 33
2020
Q4
$1.37M Buy
+39,353
New +$1.4M 1.35% 36

Other funds holding PBH

Robbins Farley's PBH Position: Q1 2026 in Review

Robbins Farley sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 371 shares — an estimated $22.9K sold.

Robbins Farley first reported a position in PBH in Q4 2020 and held it in 19 quarters. The position peaked at $2.4M in Q3 2024. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Robbins Farley reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Robbins Farley sold 371 Prestige Consumer Healthcare shares in Q1 2026, an estimated $22.9K.
  • Robbins Farley first reported a position in Prestige Consumer Healthcare in Q4 2020 and held it in 19 quarters.
  • Robbins Farley's Prestige Consumer Healthcare position peaked at $2.4M in Q3 2024.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Robbins Farley's 13F filing for Q1 2026, filed 17 Apr 2026.